{"name":"Ramsey, Bonnie, MD","slug":"ramsey-bonnie-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"standardized turmeric root extract","genericName":"standardized turmeric root extract","slug":"standardized-turmeric-root-extract","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"standardized turmeric root extract","genericName":"standardized turmeric root extract","slug":"standardized-turmeric-root-extract","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQMk1HcXR4YnhpLVpub1BKTzJvdzdHWUxTNE5JeDl1b3Z6WFFna2F2OXFEQjhfbGdxNlFjaGI1OGZzODdIZFlXTTNzTzh1TEtrcml2WGJpMTJYT0VYS3BvNUlZQzRoMmJiem1qUGlhckF3VWJDSFREa0tEMHRXc3BDUS1qVjZfRFJxNkpBMkU3My10dzRhUkNib18wTEZkQlk2dE0tQl8yV0NVNmh0MjBj?oc=5","date":"2024-02-07","type":"trial","source":"Cystic Fibrosis News Today","summary":"In Phase 3 CF trials, 'vanza triple' CFTR modulator therapy bests Trikafta - Cystic Fibrosis News Today","headline":"In Phase 3 CF trials, 'vanza triple' CFTR modulator therapy bests Trikafta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBESW9zemswWjBQdVh0Q2VBRDBpWVNpOER4eF9IZUpfdVN1cVVjUUMwcDRIZWY2VkNPN3JjLTJZc3BhMkRWUEtkXzE2TjliemNqc1FCMDFQVU9UZGcxcGMwVQ?oc=5","date":"2019-10-31","type":"pipeline","source":"NEJM","summary":"Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele - NEJM","headline":"Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5nbTBJeFZUM3NydFZfTGxJQkRTVmxLRzFaQWxPaW84SEpMLXR1SHlIdHN3Njg4b3ZBZVhzQVdfZ0NQcGZCMXdIUkM0Ung1azJHVmFhaDV5YmNDUldjNGtMUQ?oc=5","date":"2018-10-18","type":"pipeline","source":"NEJM","summary":"VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles - NEJM","headline":"VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPQmxJSnhiT0t5ODl4TzFuOE9JNzAxUWNzZUk4Nm5FemxiSlRnWGZQWElieXZaUkItQ1FJcTdqNl9veGxRNElBcmRfRVd5MWRCVG5QcHVMTHV5Q1ZWeGVGQ3NfYmxMRmhQUXBsdGVVUFlnQlJGaExaYXJkLUNIUDJCeUF5OTJqQmFqc01EanU4am9vR3liNFB5M0VKRE01bld2UklkVXhwRVBNcTZZYlIwdmQ4MA?oc=5","date":"2018-06-29","type":"pipeline","source":"UW Medicine | Newsroom","summary":"Bonnie Ramsey awarded Alpert Prize for trailblazing cystic fibrosis discoveries - UW Medicine | Newsroom","headline":"Bonnie Ramsey awarded Alpert Prize for trailblazing cystic fibrosis discoveries - UW Medicine | Newsroom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1yOVRZbDV3VDBjVU9kdV9HczAtSTVUZVBTci1VRFN5dndvRElXcmMwOEZuWVM1OXhKOVpscjFmN2RWQjlQei1nOUlNOTBhM2lyazJCeUhKaTNCeE9ramJlUw?oc=5","date":"2017-09-27","type":"pipeline","source":"NEJM","summary":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation - NEJM","headline":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE55UmN1VFVvMWpQTEhWbkFBaWpINlNKdjJ3OXdKVUhfdzluVnZGX2Z5cVBiSzZEdHhSR21iR0dqcndIUTdxa3k3Yml5bXRFRG1UdTVWSkppaFVrcmp4alI4bg?oc=5","date":"2015-05-17","type":"pipeline","source":"NEJM","summary":"Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR - NEJM","headline":"Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}